Research Grants 3,554 show all


$28.4M
2016

$27.8M
2017

$36M
2018

$30.2M
2019

$8.5M
2020

Patents 349show all

  • 124
    A61K - Preparations for medical, dental, or toilet purposes
  • 84
    C12N - Microorganisms or enzymes
  • 64
    C07K - Peptides
  • 60
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 55
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 24
    A01K - Animal husbandry
  • 19
    C07D - Heterocyclic compounds
  • 16
    C07H - Sugars
  • 12
    G01R - Measuring electric variables
  • 10
    C12Y - Enzymes

Publications 9,734 show all

  • 270
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 213
    Prostatic Neoplasms/radiotherapy
  • 168
    Antineoplastic Agents/therapeutic use
  • 121
    Neoplasms/drug therapy
  • 120
    Ovarian Neoplasms/drug therapy
  • 98
    Lung Neoplasms/drug therapy
  • 93
    Antineoplastic Agents/pharmacology
  • 90
    Breast Neoplasms/genetics
  • 81
    Mutation
  • 79
    Carcinoma, Non-Small-Cell Lung/drug therapy

Clinical Trials 279show all

102Phase 258N/A48Phase 120Phase 1/Phase 218Phase 311Other

Contact Information

Fox Chase Cancer Center, 333 Cottman Avenue
Philadelphia, PA 19111
United States